Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Molecular & Cellular Proteomics : MCP
|
July 24, 2019
Multibatch TMT Reveals False Positives, Batch Effects and Missing Values
Alejandro Brenes, Jens Hukelmann, Dalila Bensaddek, et al.
European Journal of Immunology
|
September 10, 2022
Super-killer CTLs are generated by single gene deletion of Bach2
Philippa R Barton, Alexander J Davenport, Jens Hukelmann, et al.
Elife
|
September 2, 2021
Tissue environment, not ontogeny, defines murine intestinal intraepithelial T lymphocytes
Alejandro J Brenes, Maud Vandereyken, Olivia J James, et al.
EMBO Reports
|
June 8, 2017
Brd4-Brd2 isoform switching coordinates pluripotent exit and Smad2-dependent lineage specification
Rosalia Fernandez-Alonso, Lindsay Davidson, Jens Hukelmann, et al.
Nature Communications
|
March 15, 2020
Phosphoproteomics identifies a bimodal EPHA2 receptor switch that promotes embryonic stem cell differentiation
Rosalia Fernandez-Alonso, Francisco Bustos, Manon Budzyk, et al.
Cell Reports
|
January 21, 2023
Proteomic profiling reveals distinct phases to the restoration of chromatin following DNA replication
Vanesa Alvarez, Susanne Bandau, Hao Jiang, et al.
Frontiers in Immunology
|
December 12, 2024
Lack of phosphatidylinositol 3-kinase VPS34 in regulatory T cells leads to a fatal lymphoproliferative disorder without affecting their development
Christina J F Courreges, Elizabeth C M Davenport, Benoit Bilanges, et al.
The Journal of Clinical Investigation
|
April 6, 2021
Hypoxia drives murine neutrophil protein scavenging to maintain central carbon metabolism
Emily R Watts, Andrew Jm Howden, Tyler Morrison, et al.
Journal for Immunotherapy of Cancer
|
July 22, 2024
First-in-human dose escalation trial to evaluate the clinical safety and efficacy of an anti-MAGEA1 autologous TCR-transgenic T cell therapy in relapsed and refractory solid tumors
Martin Wermke, Tobias A W Holderried, Jason John Luke, et al.
Nature Medicine
|
April 9, 2025
Autologous T cell therapy for PRAME<sup>+</sup> advanced solid tumors in HLA-A*02<sup>+</sup> patients: a phase 1 trial
Martin Wermke, Dejka M Araujo, Manik Chatterjee, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Molecular & Cellular Proteomics : MCP
|
July 24, 2019
Multibatch TMT Reveals False Positives, Batch Effects and Missing Values
Alejandro Brenes, Jens Hukelmann, Dalila Bensaddek, et al.
European Journal of Immunology
|
September 10, 2022
Super-killer CTLs are generated by single gene deletion of Bach2
Philippa R Barton, Alexander J Davenport, Jens Hukelmann, et al.
Elife
|
September 2, 2021
Tissue environment, not ontogeny, defines murine intestinal intraepithelial T lymphocytes
Alejandro J Brenes, Maud Vandereyken, Olivia J James, et al.
EMBO Reports
|
June 8, 2017
Brd4-Brd2 isoform switching coordinates pluripotent exit and Smad2-dependent lineage specification
Rosalia Fernandez-Alonso, Lindsay Davidson, Jens Hukelmann, et al.
Nature Communications
|
March 15, 2020
Phosphoproteomics identifies a bimodal EPHA2 receptor switch that promotes embryonic stem cell differentiation
Rosalia Fernandez-Alonso, Francisco Bustos, Manon Budzyk, et al.
Cell Reports
|
January 21, 2023
Proteomic profiling reveals distinct phases to the restoration of chromatin following DNA replication
Vanesa Alvarez, Susanne Bandau, Hao Jiang, et al.
Frontiers in Immunology
|
December 12, 2024
Lack of phosphatidylinositol 3-kinase VPS34 in regulatory T cells leads to a fatal lymphoproliferative disorder without affecting their development
Christina J F Courreges, Elizabeth C M Davenport, Benoit Bilanges, et al.
The Journal of Clinical Investigation
|
April 6, 2021
Hypoxia drives murine neutrophil protein scavenging to maintain central carbon metabolism
Emily R Watts, Andrew Jm Howden, Tyler Morrison, et al.
Journal for Immunotherapy of Cancer
|
July 22, 2024
First-in-human dose escalation trial to evaluate the clinical safety and efficacy of an anti-MAGEA1 autologous TCR-transgenic T cell therapy in relapsed and refractory solid tumors
Martin Wermke, Tobias A W Holderried, Jason John Luke, et al.
Nature Medicine
|
April 9, 2025
Autologous T cell therapy for PRAME<sup>+</sup> advanced solid tumors in HLA-A*02<sup>+</sup> patients: a phase 1 trial
Martin Wermke, Dejka M Araujo, Manik Chatterjee, et al.
Page
of 2